Vaccinia virus (ATCC® VR-2379)

Classification: Poxviridae, Orthopoxvirus  /  Product Format: frozen

Permits and Restrictions

View Permits

Classification Poxviridae, Orthopoxvirus
Agent Vaccinia virus
Strain RPmuhr23HA+ [recombinant of Utrecht strain RPuhr23]
in suitable host, produces protein hemagglutinin
Biosafety Level 2

Biosafety  classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Vaccinia/rabbitpox recombinant
Product Format frozen
Storage Conditions -70°C or colder
Sequences cloned into pHGN3 (ATCC 69051) can be integrated into this virus by transfection of a virus-infected host.
Recombinants can be identified by inactivation of the hemagglutinin gene (HA-).
This is a potential human pathogen.
Parent strain RPuhr23 is a spontaneous white pock mutant of wild-type rabbitpox. The HA inserted in ATCC VR-2379 can serve as a cloning site for genes affecting vaccinia and rabbitpox. ATCC 69051 is a shuttle vector for use with this system.
Avirulent, hemagglutinin positive (HA+) recombinant, derived from the white pock deletion mutant of rabbit poxvirus. Part of a virulence testing system to be used with pHGN3 (ATCC 69051).
The insert contains approximately 443 bp 5' flanking sequence, 988 bp coding sequence and 408 bp 3' flanking sequence.
Constructed by introducing the hemagglutinin gene from vaccinia virus IHD-J by homologous recombination.
Effect on Host
Cytopathic effects in tissue culture
Effect on Host
Cytopathic effects in tissue culture
Name of Depositor University of Florida, Gainesville, RW Moyer, University of Florida, Gainesville
U.S. Patent Number
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished.
Vaccinia/rabbitpox recombinant

Moyer RW, Bloom DC. Biological system for constructing and testing viral vaccines. US Patent 5,212,057 dated May 18 1993

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customer Acceptance of Responsibility, ATCC Form 62 required for distribution.
  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
  • USDA APHIS VS 16-6 or 16-6A permit must be obtained and a copy of the permit must be sent to ATCC in advance of shipment. The Application Form VS 16-3 (Import controlled material import or transport organisms or vectors) must be submitted to USDA APHIS Veterinary Services to obtain the VS 16-6 or 16-6A permit.
Basic Documentation